Clinical Management of Euglycemic Ketoacidosis in a Cat With Congenital Diabetes Mellitus Treated With Insulin and Dapagliflozin
With the introduction of sodium-glucose linked cotransporter 2 inhibitors, clinicians should be aware of EDKA and its management. This case report describes how the treatment of EDKA in cats, similar to treatment in people, may require proactive, aggressive glucose supplementation, treatment with short-acting soluble insulin, and vigilant electrolyte and acid-base monitoring. It also showcases the possibility of dapagliflozin having effect days beyond drug cessation.
Authors
- Maria Joana Dias (ORCID: https://orcid.org/0000-0002-5810-6997)
- Stijn Niessen (ORCID: https://orcid.org/0009-0000-9667-6678)
- Rodolfo Oliveira Leal (ORCID: https://orcid.org/0000-0002-2463-4062)
- Beatriz Mendoza (ORCID: https://orcid.org/0000-0002-1083-0118)
- Miguel Carvalho
- Patricia Lunet Marques
Institutions
- Royal Veterinary College (GB)
- University of Lisbon (PT)
- Centre for Research in Anthropology (PT)
Publication Details
- Journal
- Journal of Veterinary Emergency and Critical Care
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/vec.13458
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29